HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases
2021 · World Neurosurgery · 8 citations
https://doi.org/10.1016/j.wneu.2021.05.096
A
Andreas Junker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
2.5K
Citations
25
h-index
33
i10-index
Andreas Junker is an academic researcher from Essen University Hospital. The author has contributed to research in topics: Multiple Sclerosis Research Studies & MicroRNA in disease regulation & Glioma Diagnosis and Treatment. The author has an h-index of 25, co-authored 57 publications.
ORCID: 0000-0002-8063-9765Papers by this author
worksFibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?
2023 · Neuropathology and Applied Neurobiology · 7 citations
https://doi.org/10.1111/nan.12935
Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report
2019 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-019-6183-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat